Mendelspod
Mendelspod Podcast
Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity
0:00
-31:11

Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity

Harlan Robins is the Chief Scientific Officer at Adaptive Biotechnologies in Seattle. In 2014, Harlan and his brother Chad co-founded Adaptive as a spinout from the Fred Hutchinson Cancer Center where Harlan had served as the head of computational biology. Adaptive has been developing what they call "immune medicine" mainly in the area of cancer. When the corona virus pandemic hit, they came out with the world’s first T cell-based COVID diagnostic. The test has garnered them a lot of data on T cell response to COVID.

Discussion about this podcast

Mendelspod
Mendelspod Podcast
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.